Evofem Biosciences, Inc. (EVFM)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
We’re sorry, we weren’t able to find any data.
Please try reloading the page.
Trading Information
Stock Price History
| Beta (5Y Monthly) | -0.34 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 21.3000 |
| 52 Week Low 3 | 1.0100 |
| 50-Day Moving Average 3 | 4.0268 |
| 200-Day Moving Average 3 | 7.7038 |
Share Statistics
| Avg Vol (3 month) 3 | 280.41k |
| Avg Vol (10 day) 3 | 661.09k |
| Shares Outstanding 5 | 163.14M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 150.57M |
| % Held by Insiders 1 | 1.20% |
| % Held by Institutions 1 | 22.58% |
| Shares Short (Dec 14, 2021) 4 | 24.59M |
| Short Ratio (Dec 14, 2021) 4 | 6.49 |
| Short % of Float (Dec 14, 2021) 4 | 15.27% |
| Short % of Shares Outstanding (Dec 14, 2021) 4 | 15.07% |
| Shares Short (prior month Nov 14, 2021) 4 | 26.67M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Jan 17, 2018 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:6 |
| Last Split Date 3 | Jan 17, 2018 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2020 |
| Most Recent Quarter (mrq) | Sept 29, 2021 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -3,410.45% |
Management Effectiveness
| Return on Assets (ttm) | -114.83% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 4.84M |
| Revenue Per Share (ttm) | 0.04 |
| Quarterly Revenue Growth (yoy) | 515.80% |
| Gross Profit (ttm) | 78k |
| EBITDA | -164.28M |
| Net Income Avi to Common (ttm) | -194.24M |
| Diluted EPS (ttm) | -1.7520 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.86M |
| Total Cash Per Share (mrq) | 0.09 |
| Total Debt (mrq) | 102.61M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.58 |
| Book Value Per Share (mrq) | -0.38 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -164.48M |
| Levered Free Cash Flow (ttm) | -117.43M |
